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Abstract
The etiology of emotion-related disorders such as anxiety or affective disorders is considered to be complex with an
interaction of biological and environmental factors. Particular evidence has accumulated for alterations in the dopaminergic
and noradrenergic system – partly conferred by catechol-O-methyltransferase (COMT) gene variation – for the adenosinergic
system as well as for early life trauma to constitute risk factors for those conditions. Applying a multi-level approach, in a
sample of 95 healthy adults, we investigated effects of the functional COMT Val158Met polymorphism, caffeine as an
adenosine A2A receptor antagonist (300 mg in a placebo-controlled intervention design) and childhood maltreatment
(CTQ) as well as their interaction on the affect-modulated startle response as a neurobiologically founded defensive reflex
potentially related to fear- and distress-related disorders. COMT val/val genotype significantly increased startle magnitude in
response to unpleasant stimuli, while met/met homozygotes showed a blunted startle response to aversive pictures.
Furthermore, significant gene-environment interaction of COMT Val158Met genotype with CTQ was discerned with more
maltreatment being associated with higher startle potentiation in val/val subjects but not in met carriers. No main effect of
or interaction effects with caffeine were observed. Results indicate a main as well as a GxE effect of the COMT Val158Met
variant and childhood maltreatment on the affect-modulated startle reflex, supporting a complex pathogenetic model of
the affect-modulated startle reflex as a basic neurobiological defensive reflex potentially related to anxiety and affective
disorders.
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Introduction
The etiology of anxiety and affective disorders is considered to
be complex with an interaction of biological factors and
environmental influences: Family and twin studies propose a
genetic contribution to the pathogenesis of these disorders with an
estimated heritability of 30 to 60% [1–3]. The remaining part of
the variance has been attributed to environmental factors [3,4].
Particular evidence is accumulating for the catechol-O-methyl-
transferase (COMT) as a promising candidate gene in the
pathogenesis of anxiety and affective disorders: COMT catalyzes
the inactivation of monoaminergic neurotransmitters, particularly
dopamine and norepinephrine, by an extraneural transfer of a
methyl group to catechol compounds. Significantly elevated
erythrocyte COMT activity has been reported in patients with
anxiety states [5] and COMT inhibitors are effectively used in the
treatment of anxiety symptoms in Parkinson’s disease [6]. A single
nucleotide polymorphism (472G/A) in the COMT gene, located on
chromosome 22q11.2 [7], causes an amino acid change from
valine to methionine at position 158 (Val158Met), with the val
allele (472G) conferring an at least 40% higher COMT activity
[8,9]. This more active val allele has been reported to be
associated with panic disorder [10–13], phobic anxiety [14],
neuroticism [15], harm avoidance [16] and generalized anxiety
[17]. However, there are also reports indicating no influence of
COMT Val158Met on anxiety disorders or related phenotypes
[18–23] or demonstrating association of the less active met allele
with anxiety-related phenotypes [24–32]. Association studies of the
COMT Val158Met polymorphism with respect to affective
disorders, in particular depression, are similarly inconclusive
[33–35].
Three aspects might have to be taken into consideration in
order to reconcile these inconsistent molecular genetic findings
and to elucidate the genetic underpinnings of anxiety/affective
disorders in a more comprehensive way: 1) intermediate pheno-
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and 3) interaction of genetic and environmental factors.
1) Specification to unravel the influence of genetic factors on
complex traits or diseases can be reached by investigation of
so-called endophenotypes on an intermediate level between
genetic factors and categorical disease phenotypes [36]. The
acoustic startle response and particularly the affect-modulat-
ed acoustic startle response are neurobiologically founded
behavioral measures of emotional reactivity reflecting a
defensive motivational state [37–46]. Accordingly, there is
evidence for exaggerated startle potentiation in response to
negative emotional stimuli in anxiety disorders [39–41,46–
48] and fear- or anxiety/distress-related states [37,49]. Twin
studies provide evidence for a genetic influence on different
components of the startle reflex (heritability: ,30–70%; [50–
54]), with several studies having investigated the possible role
of COMT gene variation: Montag et al. [55] found greater
startle responses for met homozygotes in the unpleasant
condition of an acoustic affect-modulated startle paradigm,
while Pauli et al. [56] using the same paradigm failed to
discern any influence of COMT gene variation on startle
modulation. Armbruster et al. [57] discerned a significant
COMT Val158Met genotype effect on average startle
magnitudes across conditions with met/met carriers showing
the highest and val/val homozygotes showing the lowest
startle response, while no influence of COMT genotype on the
emotional modulation of the startle reflex was detected.
Lonsdorf et al. [31] and Klumpers et al. [58] did not discern
any effect of COMT Val158Met on fear-potentiated startle
during acquisition of fear conditioning or during instructed
fear, respectively.
2) The dopamine/norepinephrine system, as crucially driven by
the COMT Val158Met polymorphism, ought not to be
considered in an isolated way with respect to the modulation
of anxiety or related phenotypes, but rather in interaction
with other relevant neurotransmitter systems. Animal and
human studies have e.g. suggested a tight functional link
between the dopamine and the adenosine system on a cellular
as well as a neurotransmitter level [59–61]. Caffeine, which is
an antagonist at the adenosine A2A receptor and acts as a
potent anxiogenic and arousal-increasing substance [62,63],
has been reported to increase acoustic startle reflex amplitude
and confer a delayed habituation of acoustic startle blink
amplitude [64–66]. In addition, we have previously observed
a significant interactive effect of adenosine A2A receptor gene
variation, caffeine intervention and emotional stimuli on
startle magnitudes [67]. The COMT Val158Met polymor-
phism as a potent genetic modulator of dopaminergic
signaling on the one hand and caffeine administration on
the other hand might thus serve as valid biological measures
to investigate the interactive influence of the dopaminergic
and the adenosinergic system on the affect-modulated startle
response.
3) Given the complex-genetic nature of anxiety disorders
entailing an interactive pathogenetic effect of genetic and
environmental factors, neglect of environmental factors might
have introduced a major bias to previous genetic studies.
There is converging evidence for a crucial role of abuse [68–
70] and loss/separation experiences [71,72] on the patho-
genesis of anxiety disorders [73], with childhood and
adolescence being considered as particularly sensitive periods
[74]. In mice, prolonged pre-pubertal stress enhanced the
acoustic startle reflex [75]. Consistently, early environmental
stressors such as perceived childhood physical and sexual
abuse experiences have been shown to increase baseline
startle reactivity in humans [76; but 77]. With respect to the
interactive influence of COMT gene variation and life events
in anxiety, only few gene-environment interaction (GxE)
studies are available: Kolassa et al. [78] reported a GxE
interaction of the Val158Met polymorphism and traumatic
events in the etiology of posttraumatic stress disorder, with val
allele carriers showing a trauma quantity dependent disease
risk, while met homozygotes exhibited a high risk for PTSD
independently of the severity of traumatic load. In contrast,
no interaction effect was found between Val158Met and early
adversity or stressor experiences on anxiety in young children
[23] or anxiety-related traits [19], respectively.
Given these multi-level factors possibly modulating the influence
of COMT gene variation on anxiety and affective disorders or
related phenotypes, in the present study applying an integrative
approach using the same study design as in Domschke et al. [67]
we set out to elucidate the main as well as interactional effects of
COMT gene variation, caffeine and childhood maltreatment on
the affect-modulated startle response as a neurobiological measure
of emotional and motivational processes potentially related to fear-
and anxiety/distress-related states.
Results
Descriptive Data
Five of 95 examined participants showed too many zero startle
responses (,5 mV; 2.5 standard deviations above mean value) and
were therefore excluded from further analyses. For all affect-
modulated startle responses, no outliers (.2.5 SD) were detected.
For the mean intertrial interval (ITI) startle response, one subject
was additionally excluded because of an extreme score (.2.5 SD),
so that this analysis step was run with 89 participants only.
For age and CTQ, no differences were observed between sex
(male vs. female probands), challenge conditions (caffeine vs.
placebo) or COMT Val158Met genotype groups (data not shown).
Descriptive statistics of age, CTQ and startle (ITI startle, startle
after unpleasant and pleasant picture (International Affective
Picture System; IAPS) presentation, startle magnitude potentiation
after unpleasant picture presentation compared to neutral pictures
[Diffunpl-neutr]) for the 90 probands are given in table 1.
In the present sample, CTQ sum scores ranged between a
minimum of 26 and a maximum of 52 (mean=33.23, SD=5.60).
Gene-Environment Correlation (rGE)
No significant gene-environment correlation between COMT
Val158Met genotypes and CTQ was observed (rGE=20.01,
p=0.92). Thus, confounding effects of a correlation between
genetic and environmental predictors could be excluded.
Influence of COMT Val158Met on baseline startle reflex
No influence of COMT Val158Met genotype on mean ITI
startle response was observed (F(2,87)=0.24, p=0.79).
Influence of COMT Val158Met, sex and challenge
condition on affect-modulated startle
Because of the large variance of caffeine saliva concentrations
especially in the placebo group (range: 0–132 mg/l), all subjects
with a concentration differing more than one and a half
interquartile ranges from the respective median in the placebo
or verum group were excluded for analyses including challenge
condition as an additional between-subjects factor. For this reason,
COMT, Early Trauma and Affect-Modulated Startle
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subjects for analyses including challenge condition (see table 1).
According to Mauchlys test, sphericity assumption was violated
(x
2(2)=19.23, p,0.001), so that Huynh-Feld correction was used
(e=0.95). In the presently analyzed sample of N=85 probands,
ANOVA revealed a significant effect of picture valence on startle
magnitude (F(2,146)=26.97, p,0.001), representing a linear trend
(F(1,73)=47.06, p,0.001) with increasing startle magnitudes from
pleasant to unpleasant pictures.
Furthermore, significant interactions between COMT Val158-
Met genotype and picture valence (F(4,146)=3.99, p=0.005) and
between sex and picture valences (F(2,146)=4.43, p=0.015) were
observed. No significant interaction between challenge condition
and picture valence (F(2,146)=0.17, p=0.83) and no significant 3-
or 4-way-interactions between picture category and the between-
subjects factors (COMT Val158Met genotype, sex, challenge
condition) were observed, respectively (data not shown).
Post-hoc t-tests revealed a significantly increased startle response
to unpleasant pictures in comparison to neutral pictures in val
homozygotes (t(12)=3.98, p=0.002), but not in met homozygotes
(t(29)=0.98, p=0.34). Vice versa, a significantly decreased startle
response to pleasant pictures compared to neutral pictures was
observed in met homozygotes (t(29)=5.28, p,0.001), but not in
homozygotes for the val allele (t(12)=0.24, p=0.82). For carriers
of the val/met genotype, no differences, neither in response to
unpleasant compared to neutral pictures (t(41)=1.37, p=0.18) nor
in response to neutral compared to pleasant pictures (t(41)=1.47,
p=0.16) were observed (see figure 1).
Post-hoc t-tests stratified for sex revealed a significantly
increased startle response in response to unpleasant pictures in
comparison to neutral pictures in female subjects (t(39)=4.22,
Table 1. Descriptive characteristics of probands by sex, challenge condition and COMT Val158Met genotype.
Male Female Caffeine Placebo
Variable N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD
Total sample
Age (years) 90 26.46 6.22 45 27.00 5.93 45 25.91 6.51 43 25.98 5.29 42 26.60 6.80
CTQ (sum) 90 33.23 5.60 45 32.71 4.66 45 33.76 6.41 43 32.88 5.51 42 33.57 5.92
ITI startle 89 37.29 26.46 44 35.55 26.26 45 39.00 26.84 43 35.54 24.76 41 39.66 28.51
Startle unpl 90 51.38 2.62 45 50.57 2.26 45 52.19 2.73 43 51.45 3.03 42 51.24 2.19
Startle pl 90 48.64 1.79 45 48.91 1.50 45 48.38 2.02 43 48.68 1.89 42 48.81 1.69
Diffunpl-neutr 90 1.42 4.48 45 20.01 3.90 45 2.85 4.61 43 1.58 5.16 42 1.30 3.76
Sample stratified by genotype
COMT val/val
Age (years) 15 25.47 4.87 6 26.17 4.54 9 25.00 5.29 7 26.29 4.35 6 23.17 0.98
CTQ (sum) 15 32.87 4.24 6 33.83 3.97 9 32.22 4.52 7 32.86 2.85 6 33.00 5.97
ITI startle 15 36.13 23.95 6 23.69 21.76 9 44.42 22.68 7 34.49 24.27 6 31.09 22.75
Startle unpl 15 53.16 2.14 6 52.72 0.99 9 53.45 2.68 7 53.50 2.48 6 52.77 2.23
Startle pl 15 48.02 1.69 6 48.23 1.07 9 47.87 2.05 7 48.17 1.29 6 48.46 2.07
Diffunpl-neutr 15 4.41 3.99 6 3.75 1.96 9 4.84 4.99 7 5.22 5.24 6 3.99 2.95
COMT val/met
Age (years) 42 25.83 6.07 22 26.45 5.79 20 25.15 6.45 22 24.45 3.46 20 27.35 7.86
CTQ (sum) 42 33.40 6.01 22 33.27 5.13 20 33.55 6.98 22 33.05 6.27 20 33.80 5.85
ITI startle 41 34.00 19.95 21 34.60 18.38 20 33.36 21.95 22 30.61 15.89 19 37.91 23.66
Startle unpl 42 50.89 2.79 22 50.29 2.54 20 51.56 2.97 22 50.86 3.32 20 50.93 2.15
Startle pl 42 49.28 1.81 22 49.13 1.57 20 49.44 2.07 22 49.41 2.04 20 49.12 1.55
Diffunpl-neutr 42 1.00 4.73 22 20.42 4.43 20 2.56 4.65 22 1.07 5.47 20 0.92 3.89
COMT met/met
Age (years) 33 27.70 6.88 17 28.00 6.67 16 27.38 7.29 14 28.21 7.28 16 26.94 6.50
CTQ (sum) 33 33.18 5.75 17 31.58 4.26 16 34.88 6.72 14 32.64 5.54 16 33.50 6.37
ITI startle 33 41.92 33.77 17 40.90 34.62 16 43.01 33.95 14 43.80 34.44 16 44.95 35.50
Startle unpl 33 51.19 2.31 17 50.17 1.82 16 52.28 2.32 14 51.36 2.46 16 51.06 2.13
Startle pl 33 48.12 1.57 17 48.87 1.53 16 47.33 1.22 14 47.77 1.43 16 48.54 1.75
Diffunpl-neutr 33 0.59 3.90 17 20.82 2.94 16 2.08 4.31 14 0.55 4.06 16 0.77 3.63
ITI startle = startle response during the intertrial interval in mV (ITI); Startle unpl = startle response after presentation of unpleasant IAPS pictures (in mV; T-transformed);
Startle pl = startle response after presentation of pleasant IAPS pictures (in mV; T-transformed); Diffunpl-neutr = potentiation of startle magnitude by unpleasant IAPS
pictures (in mV; T-transformed values: contrast unpleasant/neutral pictures); CTQ = Childhood Trauma Questionnaire (sum score).
Note: Because of the large variance of caffeine saliva concentrations (difference of more than one and a half interquartile ranges from the respective median in the
placebo or verum group) five subjects were excluded, leaving 85 subjects for further analyses when considering challenge condition. For the mean ITI startle response,
one subject was excluded because of an extreme score (. three SD).
doi:10.1371/journal.pone.0039709.t001
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significantly increased startle response to neutral pictures com-
pared to pleasant pictures was observed in male subjects
(t(44)=4.68, p,0.001), but not in female participants
(t(39)=1.18, p=0.25).
Using untransformed raw startle data, the results remained
stable, showing a significant effect of picture valence on startle
magnitude, a significant interaction between COMT Val158Met
genotype and picture valence and, a significant interaction
between sex and picture valence (data not shown).
Influence of COMT Val158Met and CTQ on baseline
startle reflex
Investigating influences of CTQ on mean ITI startle response
for each COMT Val158Met genotype separately, no associations
were observed, neither for subjects carrying the COMT val/val
genotype (b=20.40, t=21.59, p=0.14), nor for val/met
(b=20.05, t=20.29, p=0.77) or met/met genotype carriers
(b=20.15, t=20.83, p=0.41).
Influence of COMT Val158Met and CTQ on affect-
modulated startle reflex
After presentation of unpleasant pictures, only for val homozy-
gotes a significant influence of CTQ on startle response was
observed: val/val carriers showed an increased startle when at the
same time scoring high on the CTQ (b=0.52, t=2.18, p,0.05).
No influence of CTQ on the startle reflex after unpleasant picture
presentation was observed in val/met (b=20.24, t=21.55,
p=0.13) carriers or met homozygotes (b=0.05, t=0.30, p=0.77).
After neutral picture presentation, startle responses for none of
the COMT Val158Met genotype groups were influenced by CTQ
(val/val: b=20.15, t=20.56, p=0.59; val/met: b=0.24,
t=1.54, p=0.13; met/met: b=0.12, t=0.69, p=0.50).
After pleasant picture presentation, a marginally significant
decrease of the startle response was observed for val homozygotes
dependent on an increase in CTQ scores (b=20.51, t=22.16,
p=0.05), while no associations were observed for val/met
(b=0.15, t=0.97, p=0.34) or met/met genotype carriers
(b=20.21, t=21.17, p=0.25), respectively.
The interaction of COMT Val158Met genotypes and CTQ
scores after presentation of unpleasant and pleasant pictures,
respectively, is shown in figure 2.
Hierarchical Multiple Regression
Based on the above mentioned results, influences of COMT
Val158Met genotype, sex and CTQ as well as their interactive
influence on startle magnitude potentiation after unpleasant IAPS
picture presentation compared to neutral pictures (Diffunpl-neutr)
were tested. Additionally, based on the observed results (see
figure 2), COMT Val158Met genotypes were grouped reflecting a
recessive model for the val allele (COMT val/val vs. met allele
carriers).
In step 1, significant main effects of sex and COMT Val158Met
genotype were observed, while CTQ alone did not affect startle
magnitude potentiation. In step 2, in addition to the main effects
of sex and COMT Val158Met genotypes, a significant interaction
between COMT Val158Met genotypes and CTQ on startle
magnitude potentiation (Diffunpl-neutr) was discerned. The addition
of a GxE interaction term in step 2 accounted for a significant
increment in explained variance. The inclusion of interactions
with sex in step 3, did not significantly increase the explained
variance. No significant interaction terms with sex were observed
(see table 2).
Post-hoc t-tests of the main effects revealed a significantly
increased startle magnitude potentiation in female subjects
compared to males (t(88)=3.18, p=0.002) and in val homozygotes
compared to met allele carriers (t(88)=2.95, p=0.004).
Neither main nor interactive effects of COMT Val158Met
genotype, sex and CTQ were observed on startle magnitude
differences after neutral IAPS picture presentation compared to
pleasant pictures (Diffneutr-pl) (data not shown). Accordingly,
neither the GxE interaction term in step 2 (DR
2=0.000,
DF(1,85)=0.03, p=0.87) nor interactions with sex in step 3
(DR
2=0.014, DF(3,82)=0.40, p=0.76) significantly increased the
explained variance.
Discussion
In the present study, we observed a significant influence of
COMT Val158Met genotype as well as an interactive effect of
COMT Val158Met genotype and childhood maltreatment (CTQ)
on the affect-modulated startle response: 1) Subjects homozygous
for the more active val allele showed significant startle potentiation
in response to unpleasant pictures, while met allele homozygotes
displayed a blunted startle response to unpleasant stimuli and a
significantly decreased startle response to pleasant stimuli. 2)
Subjects homozygous for the val allele and at the same time
scoring high on the CTQ showed increased potentiation of the
startle magnitude after unpleasant picture presentation and a
significantly decreased startle response to pleasant stimuli. 3) No
influence of caffeine on affect-modulated startle responses
dependent on the COMT Val158Met polymorphism could be
discerned.
Ad 1) We discerned significant startle potentiation in response to
unpleasant stimuli in homozygous carriers of the more active
COMT val allele. This pattern corresponds to the expected
modulation of the startle response by aversive stimuli constituting
an inherently defensive response [38,44] reported in both healthy
probands [44,45] as well as in anxiety and anxiety disorders [39–
41,46–48]. Val allele carriers did not show significant modulation
in response to pleasant pictures, potentially due to a relatively
Figure 1. Mean startle magnitude modulated by picture
category and COMT Val158Met genotype. *** significant at
significance level of p#.005.
doi:10.1371/journal.pone.0039709.g001
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startle modulation by positive pictures, however, is not uncommon
and not as reliably replicated as the startle potentation in response
to aversive stimuli [37].
Some support for a modulatory influence of the val allele on
startle potentiation by aversive stimuli as presently observed might
be derived from studies reporting COMT val/val genotype to
decrease prepulse inhibition (PPI) of the startle reflex [79,80]. Also,
using the COMT inhibitor tolcapone, Giakoumaki et al. [81]
observed lowered prepulse inhibition in the placebo condition and
increased prepulse inhibition in the tolcapone condition in val
homozygotes. Diminished PPI has been observed in aversive
contexts when using pictures as both prestimuli and affective
prompts [82] and along with increased fear-potentiated startle in
patients with anxiety disorders [43,83–85]. However, there is
experimental evidence for valence modulation and prepulse
inhibition to constitute completely independent startle modulatory
phenomena [86], thus rendering hypotheses regarding the relation
between the genetic modulation of affect-modulated startle on the
one hand and prepulse inhibition one the other hand highly
speculative.
Figure 2. Linear regression analysis of CTQ sum score influence on startle magnitude potentiation after unpleasant and pleasant
IAPS pictures stratified by COMT Val158Met genotype.
doi:10.1371/journal.pone.0039709.g002
Table 2. Results of hierarchical multiple regression analysis regarding affect-modulated startle magnitude (contrast unpleasant/
neutral IAPS pictures; Diffunpl-neutr).
Step 1
Statistics
Step 2
Statistics
Step 3
Statistics
Predictors R
2 DR
2 DF (p) b t b t b t
Step 1 .191 .191** 6.75 (.001)
sex .31 3.13** .33 3.42** 26.10 21.62
COMT (val/val) .27 2.78** 25.28 22.04* 23.83 21.36
CTQ 2.12 21.20 .14 .90 .02 .13
Step 2 .232 .041* 4.59 (.035)
COMT (val/val) x CTQ 5.57 2.14* 4.15 1.48
Step 3 .263 .030 1.13 (.342)
COMT (val/val) x sex 24.23 21.12
CTQ x sex 6.37 1.69
COMT (val/val) x CTQ x sex 4.14 1.10
COMT (val/val) = val/val vs. val/met and met/met genotypes; CTQ = Childhood Trauma Questionnaire (logarithmized sum score); R
2 = coefficient of determination
(explained variance); DR
2 = increase of explained variance; DF( p )= change and significance of F-statistics; b = standardized regression coefficient; t = t-statistics.
**p,0.01 (bold); * p,0.05 (bold).
doi:10.1371/journal.pone.0039709.t002
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increased startle response to aversive stimuli has been postulated to
critically involve input from the amygdala [38,87]. The COMT val
allele has previously been shown to be associated with increased
amygdala activation during processing of aversive stimuli such as
fearful faces in healthy probands as well as in patients with panic
disorder [88–91]. Thus, increased excitability of the amygdala in
val allele carriers might constitute one of the neurobiological
underpinnings of the presently observed startle potentiation in
response to aversive stimuli. It has to be noted, though, that the
impact of COMT gene variation on amygdala response to aversive
stimuli is highly controversial with several contradictory reports of
association [92–94]. Research findings on the role of the
dopaminergic and noradrenergic system, crucially driven by
COMT activity, in mediating emotional processing is also not
unequivocal: reports of increased norepinephrine availability to
reverse the negative bias in information processing characterizing
mood and anxiety disorders and to reduce amygdala response to
fearful faces [95,96] support the present finding of the more active
COMT val allele – conferring decreased norepinephrine availabil-
ity – to increase the defensive startle reaction to aversive emotional
stimuli. Conversely, with respect to the dopaminergic system most
evidence rather points to an increase in dopaminergic signalling to
enhance limbic response to unpleasant stimuli [97,98].
Homozygosity for the less active COMT met allele, conferring
increased dopamine and norepinephrine availability, was presently
associated with a blunted affective startle response to unpleasant
stimuli and a significantly decreased startle response to pleasant
stimuli in contrast to neutral pictures. This pattern corresponds to
a study by Forbes et al. [99] showing greater startle during the
neutral condition than during the pleasant condition, but no
increase in startle during the unpleasant condition in patients with
unipolar depression. Also, several other studies provide evidence
for a diminished fear potentiated startle in depression-related states
[100–102] and in patients with anxiety disorders and comorbid
depression [103–105].
It has been suggested that affect-modulated startle response
patterns might aid in a more differentiated understanding of the
neurobiological underpinnings of anxiety disorders and depres-
sion, with enhanced fear-potentiated startle prevailing in patients
with anxiety disorders and diminished affect modulation of the
startle in patients with depression [49]. Thus, COMT gene
variation might constitute one of the neurobiological mechanisms
of this differentiation with the more active val allele potentially
increasing defense reflexes and thereby conferring a higher risk for
anxiety-related traits or disorders, respectively, while the less active
met allele seems to be rather associated with defensive responding
deficits and thereby traits or disorders on a depressive continuum.
It has to be noted, though, that categorical association studies of
COMT gene variation in both anxiety disorders [10–15,24,25,28–
30,106] and depression [33–35] yielded inconclusive results with
respect to the direction of allelic association. Also, in the present
study dimensional measures of anxiety or depressive traits were
not taken into consideration, which therefore does not allow for
inferences on the relation of the present results to psychopathol-
ogy. However, future studies investigating genetic effects on the
affect-modulated startle response as an intermediate phenotype
reflecting emotional reactivity in combination with assessment of
psychometric correlates of emotion-related mental disorders might
aid in a more neurobiologically informed understanding of the
fear-anxiety-distress spectrum.
The present results are in contrast to a study by Montag et al.
[55], who reported increased startle reflexes for met homozygotes
in the unpleasant condition of an acoustic affect-modulated startle
paradigm, and Pauli et al. [56] and Armbruster et al. [57], who
failed to discern any influence of COMT gene variation on the
emotional modulation of the startle reflex in healthy probands.
These studies differ from the present one in several aspects:
Montag et al. [55] investigated a sample of female probands only,
who were controlled for their hormonal status, while in the present
study both sexes were included and menstrual cycle phase was not
ascertained. This might have accounted for differing startle
responses across studies [107], particularly, as an estrogenic
response element in the COMT gene promoter region might
render COMT expression particularly dependent on estrogen
levels [108]. Also, in the study by Montag et al. [55] probands
were pre-stratified not only for the COMT Val158Met polymor-
phism, but also for the DRD2/ANKK1 Taq IA SNP, which could
have fundamentally influenced their results in an epistatic way.
The two studies failing to discern an effect of COMT gene
variation on affect-modulated startle response investigated pro-
bands at an older age (m: 35.16610.29 years, f:
35.00610.18 years, [56]; 61.1362.57 years, [57]) than the study
by Montag et al. [55] (22.1163.29 years) and the present one
(26.4266.11 years), which might have influenced the respective
results, as an age-related decrease in emotional recognition and
processing has been observed ([109], but: [110]).
Ad 2) Besides several possible explanations for diverging
association results of COMT Val158Met with startle response
and anxiety-/depression-related phenotypes as detailed above, the
present study might contribute to further delineating the
functional effect of COMT gene variation on vulnerability towards
fear/anxiety/distress-related states by complementing molecular
genetic information with environmental data. We identified
significant gene-environment interaction of COMT Val158Met
genotype with CTQ, with more maltreatment being associated
with higher startle potentiation in val/val subjects but not in met
carriers. This finding could reflect a possibly val allele driven
inclination of traumatized individuals to experience excessive
negative emotions, which would be in line with Kolassa et al. [78]
reporting val allele carriers to display a trauma quantity dependent
disease risk for posttraumatic stress disorder. Additionally, we
observed more childhood trauma to predispose homozygous val
allele carriers to an accentuated startle inhibition in response to
pleasant pictures. This might point to a capacity of val allele
carriers to nevertheless experience positive emotions as calming
and safety-indicating. It has been suggested that after traumatic
experiences positive emotions could buffer against depression by
‘‘correcting’’, ‘‘restoring’’ or ‘‘undoing’’ the effects of negative
emotions (e.g., [111], [112]). Based on this hypothesis, the COMT
val allele in interaction with traumatic experiences could
predispose to an increased risk of exaggerated negative emotional
processing potentially predisposing to anxiety disorders such as
PTSD (cf. [78]), while at the same time conferring resilience
against depression by restoring autonomic quiescence following
positive emotional stimuli (see [113]). However, as in the present
study only healthy probands were investigated and no measures of
coping strategies or other relevant psychometric measures were
ascertained, future studies will have to probe his hypothesis.
The present results are in contrast to a previous study by
Jovanovic et al. [76], who failed to discern an influence of early
environmental stressors on the degree of fear-potentiated startle.
As this study, however, did not include genetic information
potentially mediating the impact on early life stress on the affect-
modulated startle response, studies are not fully comparable.
Gene-environment interaction studies on the effect of COMT gene
variation on stress-related disorders are quite controversial: No
interactional impact of COMT Val158Met and life events could be
COMT, Early Trauma and Affect-Modulated Startle
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or on extraversion and neuroticism among adults, respectively
[114]. The COMT met/met genotype has, however, been shown
to interact with maternity stressors in postpartum depression [115]
and with stressors within the year preceding the onset of the first
mood disorder episode in depressive adults [116]. Furthermore,
carriers of both the 5-HTTLPR S and COMT met alleles exhibited
the greatest depressive response to chronic stress in a three-way G
x G x E interaction [117]. A possible explanation for this flip-flop
phenomenon, i.e., opposite direction of allelic association across
studies (cf. [118]), might be that different life events at different
ages might differentially interact with dopaminergic tone in
shaping the risk for different psychopathological states: As it has
been shown that early life stress comparable to the presently
investigated childhood traumata leads to decreases in the levels of
norepinephrine and dopamine in the frontal cortex and metab-
olites of dopamine and serotonin in the amygdala (cf. [119]),
carriers of the more active COMT val allele entailing a lowered
noradrenaline and dopamine tonus might be particularly suscep-
tible to the development of mental disorders related to childhood
trauma. Additionally, linkage disequilibrium with other relevant
polymorphisms, gene-gene interactions or epigenetic modifications
following early environmental stress (see [120]) have to be taken
into consideration when interpreting the present finding. Still, the
present pilot data might foster future gene-environment interac-
tion studies in fear-, anxiety- or distress-related disorders
contributing to further disentangling their complex genetic nature
(e.g., [121–123]).
Ad 3) No statistically significant influence of challenge condition
(placebo/caffeine) on affect-modulated startle responses dependent
on the COMT Val158Met polymorphism and/or childhood
trauma could be discerned. Also, genotype distribution of the
adenosine 2A receptor (ADORA2A) 1976T.C (rs5751876, for-
merly 1083T.C, Tyr/Tyr) variant, a silent polymorphism in exon
2 of the ADORA2A gene, which has previously found to be
associated with panic disorder and anxiety-related traits [124–
128], did not differ across COMT Val158Met genotype groups.
The present results thus do not support a COMT driven
interaction between the adenosinergic and the dopaminergic
system in the mediation of stress and affect-modulated startle
response. However, this interaction might not primarily be
conferred by COMT, but rather by dopamine D2 receptor
(DRD2) gene variation, as DRD2 receptors in the amygdala have
been suggested to play a role in setting up adaptive responses to
cope with aversive environmental stimuli [129] and to functionally
interact with adenosine receptors on a cellular level [130].
In addition to the caveats mentioned above, the following
limitations of our study have to be considered when interpreting
the present results: First of all, the present sample size particularly
regarding the val/val genotype group was limited. Despite there
was sufficient power (.0.90) to explain 23% of startle magnitude
variance with four predictors in step 2 with a type I error rate of
0.05 according to a post-hoc power calculation for multiple
regression using G*Power calculation software available online
(University of Duesseldorf, Germany; http://www.psycho.uni-
duesseldorf.de/abteilungen/aap/gpower3/), we cannot exclude
false positive or false negative results, respectively. Particularly,
with respect to challenge condition or sex subgroups, sample sizes
are very small and might not allow for sufficient power, although a
separate analysis conducted in the placebo group only revealed the
same effects as in the total sample and therefore might be taken as
some confirmation of our overall results. However, the present
results have to be considered pilot data, which warrant replication
in larger independent samples. Furthermore, with a mean age of
26.5 years our final sample is relatively young, so that a potentially
confounding neglect of genetic predisposition for mental disorders
manifesting at a later age cannot be excluded. Also, the average
sum score of the CTQ in the presently investigated sample is low,
indicating a small quantity of childhood maltreatment experiences
and thus potentially super-normality of the present sample.
Childhood maltreatment was assessed retrospectively, entailing
impaired accuracy and reliability of answers due to recall bias or
false answers (cf. [131]). Moreover, the CTQ is designed as a
multi-factorial questionnaire [132,133], so that subdimensions of
maltreatment (e.g., emotional abuse, sexual abuse, etc.) might even
more specifically interact with genetic factors in the etiology of
anxiety. Future studies will therefore require more complex
models of mediating and moderating factors between genes and
the investigated phenotype, particularly given that personality and
behavioral characteristics such as neuroticism or cognitive
appraisal might moderate the GxE influence on the pathogenesis
of anxiety and related intermediate phenotypes (cf. [73]).
In summary, the present results indicate a main as well as a GxE
effect of the COMT Val158Met variant and childhood maltreat-
ment on the affect-modulated startle reflex, supporting a complex
pathogenetic model of the affect-modulated startle reflex as a basic
neurobiological defensive reflex potentially related to anxiety and
affective disorders. Future, preferably longitudinal studies investi-
gating genetic and environmental effects on the affect-modulated
startle response reflecting emotional reactivity might aid in a more
neurobiologically informed understanding of the fear-anxiety-
distress spectrum.
Methods
Samples and Procedures
A sample of unrelated healthy participants (N=95; male=46,
female=49; mean age: 26.42 years, SD=6.11) was consecutively
recruited at the Departments of Psychiatry, Universities of
Muenster and Wuerzburg, Germany, in the context of a
collaborative research study. Inclusion criteria were European
descent (self-report up to 3
rd generation), right-handedness and
fluency in German. Exclusion criteria were manifest mental axis I
disorder (M.I.N.I.: [134]), pregnancy or breast feeding, severe
medical conditions, use of illegal drugs (assessed by a urine drug
screening), alcohol consumption of more than 140 g per week,
daily smoking of more than 20 cigarettes a day, caffeine or lactose
intolerance, high caffeine consumption (more than 3 cups of coffee
per day), less than a high school education, and age under 18 and
over 50 years. A blood sample (20 ml EDTA blood) was taken for
genetic analysis. Participants were asked to refrain from caffeine or
tea consumption for one week prior to the investigation and not to
smoke, consume alcohol (assessed by a breath test) or take any
medication for at least 24 h prior to the investigation. To exclude
any neurological or other somatic disorders participants under-
went a brief physical and neurological examination in a screening
session one week before the startle-experiment, where additionally
heart activity (electrocardiogram) and basic blood parameters were
checked. The protocol was approved by the ethics committees of
the Universities of Muenster and Wuerzburg, Germany, and
written informed consent was obtained from all subjects during the
screening session. The study has been conducted according to the
principles expressed in the Declaration of Helsinki.
Genotyping
All participants were genotyped for the COMT Val158Met
polymorphism according to published protocols [10,88]. Geno-
types were determined by investigators blinded for outcome
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the online available program DeFinetti (Wienker and Strom,
accessed February 2011), were fulfilled for COMT Val158Met
genotype distribution in the present sample (val/val: 17%, val/
met: 47%, met/met: 36%; p=0.792). The present sample
constitutes a subsample (due to missing data for the environmental
variable or COMT genotype) of participants included in a larger
study [67], which was originally stratified for adenosine A2A
receptor (ADORA2A) gene variation. As we have previously
observed a significant interactive effect of ADORA2A 1976T.C
genotype, caffeine intervention and picture category in the
extended sample [67], ADORA2A 1976T.C genotypes were
retrieved for also for the present sample (see [67]). Furthermore, as
there is accumulating evidence for variation in the serotonin
transporter gene (5-HTTLPR) to influence fear-potentiated startle
response [92] and to interact with stressful life events to influence
startle response or anxiety sensitivity [122,135], we additionally
genotyped our sample for this variant according to published
protocols with minor modifications (see [136,137]). Hardy-
Weinberg criteria were fulfilled for both ADORA2A 1976T.C
and 5-HTTLPR genotype distribution (both p.0.05).
Affect-modulated startle paradigm
After screening negative for drugs and pregnancy, all electrodes
were fixed and checked for impedances below 5 kV. At first, eight
startle stimuli (random intervals of one second till twelve seconds;
50 ms of 95 dB white noise with an instantaneous rise-time
presented via BoseH Around-Ear Headphones) were presented, to
get participants accustomed to the startle procedure and to
minimize outlier startle responses during the critical trials. The
experiment consisted of three blocks a ` 24 pictures and three
minute breaks between the blocks. Each block contained eight
unpleasant, eight neutral, and eight pleasant environmental cues,
derived from a total of 72 pictures from the International Affective
Picture System (IAPS: [138]); 24 of each valence, respectively).
Pictures were randomized with the constraint that not two of the
same valence (unpleasant, neutral or pleasant) were presented
successively. IAPS pictures were presented for 8 seconds each with
an intertrial interval (ITI) between 16.5 and 25.5 seconds
(mean=21 seconds). Startle probes were administered 2.5, 4.0,
or 5.5 seconds after picture onset during picture presentation as
well as 10 or 12 seconds after picture offset during the ITI. 75% of
all trials contained startle probes during picture presentation
(evenly distributed across each picture category), 12.5% of all trials
contained startle probes during the ITI and 12.5% of the trials did
not contain any startle probe. Two electrodes were placed under
the left eye [65] to measure the electromyogram (EMG) activity of
the orbicularis oculi muscle. The reference electrode was placed
on the forehead, the ground electrode was placed on the processus
mastoideus. BrainVision Analyzer 2 (Brain Products GmbH,
Gilching, Germany) was used as analyzing software, to rectify,
filter (Low Cutoff 28 Hz, High Cutoff 500 Hz, Notch 50 Hz), and
smooth the signals offline (using a time constant of 50 ms). The
difference between the highest peak 21 to 200 ms after and the
average across 50 ms before startle probe presentation was taken
as startle magnitude.
Caffeine intervention
The above mentioned startle paradigm was embedded in a
double-blind, placebo-controlled caffeine challenge study-design
(as described in detail in Domschke et al., 2012 [67]). Briefly,
caffeine intervention was performed by oral administration of
300 mg caffeine citrate (equivalent to 150 mg freebase caffeine; cf.
[61,139,140]). Participants were given a placebo or caffeine
capsule 60 minutes before starting the startle paradigm. Caffeine
levels were determined by saliva test.
Assessment of Childhood Trauma
All participants completed the German version of the Child-
hood Trauma Questionnaire [132,133], comprising 28 items with
a total sum score between a minimum of 25 and a maximum of
128 designed to retrospectively assess negative childhood experi-
ences [133,141,142]. After instruction by the investigators,
participants completed the CTQ on a computer in the laboratory
and had the opportunity to ask questions concerning the
questionnaire during the test session. The internal consistency of
the German version of the CTQ sum score was found to be
excellent (Cronbachs a=0.94; [143]). Also, the retest-reliability
(r=0.74–0.94) was found to be high [144]. The construct validity
was comparable to the original English version [143]. A distinct
convergence with other assessments of childhood maltreatment
was observed [144]. For the German version of the CTQ, mean
scores are only reported for different mental disorders and range
between 40.1 in patients with anxiety disorders up to 63 in patients
with borderline personality disorder [143].
Statistical Analysis
To control for influences of potentially extreme scores, all
analyzed startle data were checked for outliers (.2.5 SD; cf.
[145]). To prevent statistical inference errors from non-normality
of data and to reduce influences of potential outliers, CTQ score
was logarithmized using the natural log with base e (cf. [146]).
To exclude a possibly confounding influence of ADORA2A
1976T.C and 5-HTTLPR genotype distribution (see above), we
evaluated frequencies of these genotypes in COMT Val158Met
genotype groups by x
2 tests: ADORA2A 1976T.C and 5-HTTLPR
genotype distributions did not differ between COMT genotype
groups (ADORA2A: x
2=6.75, p=0.15; 5-HTTPLR: x
2=1.14,
p=0.89), sex (ADORA2A: x
2=0.59, p=0.74; 5-HTTPLR:
x
2=1.38, p=0.50) or challenge conditions (ADORA2A:
x
2=1.49, p=0.48; 5-HTTPLR: x
2=0.43, p=0.81).
Possible differences regarding age and CTQ between sex (male
vs. female participants), challenge condition (caffeine vs. placebo)
and COMT Val158Met genotype groups were analyzed by means
of T tests.
For genetic analyses, in a first step COMT Val158Met genotypes
were coded as 0, 1 and 2 for the number of val alleles. Sex was
coded as 0.5 for females and 20.5 for males, challenge condition
as 0.5 for caffeine and 20.5 for placebo (cf. [147]). To exclude
possible objectionable confounding effects, gene-environment
correlations (rGE) were analyzed using bivariate correlation
analysis.
Startle data were checked for zero responses and artifacts in
each participant. Startle reactions with no detectable responses
(fewer than 5 mV) were scored as zero. Artifacts were defined as
spontaneous eye blinks during baseline or within 20 ms after
startle probe onset and were scored as missing values. Participants
with too many zero responses (more than 2.5 standard deviations
above mean zero responses) or less than three acceptable startle
responses in any picture category were excluded from data
analysis. All startle responses were T-transformed within individ-
ual subjects in order to assure comparability of the data and to
reduce interindividual variability (as described by [65];[56]).
Despite the large variance in the untransformed raw data (startle
(in mV) after presentation of unpleasant (M=40.30, SD=30.80),
neutral (M=37.18, SD=28.27) and pleasant (M=35.08,
SD=27.08) pictures) compared to the T-transformed data (see
COMT, Early Trauma and Affect-Modulated Startle
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data.
Influence of COMT Val158Met genotype on baseline startle
response (ITI startle) was investigated using one-way ANOVA.
The affect-modulated startle responses were analyzed by
ANOVA for repeated measures with picture category (unpleasant,
neutral, and pleasant) as within-subjects factor and COMT
genotype, sex and challenge condition (caffeine vs. placebo) as
between-subjects factors. Pairwise comparisons of picture valence
were assessed by means of post-hoc T-tests.
Influence of CTQ on ITI startle response and on response after
presentation of pleasant, neutral and unpleasant pictures, respec-
tively, was examined for the three COMT Val158Met genotypes
separately by linear regression analyses.
For further genetic analyses based on the observed results
yielded by the above mentioned statistics, COMT val/met and
met/met genotypes were grouped together (0.5=val/val vs
20.5=val/met and 20.5=met/met), reflecting a recessive model
when assuming val to be the risk allele.
Also, the potentiations of the startle magnitude (T-transformed)
after unpleasant IAPS picture presentation compared to neutral
pictures (Diffunpl-neutr) and after neutral pictures compared to
pleasant pictures (Diffneutr-pl) were calculated and used as
dependent variables in the subsequent regression analyses. Based
on the observed influences of sex, COMT Val158Met genotype
and the interactive effects between COMT Val158Met genotype
and CTQ (GxE), these effects on the potentiation of the startle
magnitude were estimated by hierarchical multiple regression in a
three-step procedure: The first included sex, grouped COMT
Val158Met genotypes (see above) and logarithmized CTQ sum, in
order to evaluate main effects on startle response. In a second step,
a two-way interaction term for COMT Val158Met genotype and
CTQ was added. Step 3 contained the two-way interaction of sex
with COMT Val158Met genotype and CTQ sum and a three-way
interaction with all three predictors (COMT Val158Met genotype,
CTQ, sex). This order of variable entry enabled us to first
investigate only main effects on startle magnitude potentiation. In
a second step, we analyzed the increase in explained variance by
inclusion of GxE. Thirdly, we tested for interactions with sex.
Increase in explained variance (DR
2) in successive regression steps
was tested by means of F-test. For each regression step, Gaussian
distribution of residual variances was confirmed by a post-hoc
Kolmogorov-Smirnov test.
For all tests, a p-value ,0.05 was considered statistically
significant. All analyses were run with SPSS Version 18.0.
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